L111P (p.Leu111Pro) variant of IRS1 (Insulin receptor substrate 1)
L111P (p.Leu111Pro) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
L111P (p.Leu111Pro) variant details
- p.Leu111Pro
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.